Intriguingly, HSP90AA1 was enriched in CD4+ T-cell subsets and positively correlated with immune checkpoint molecules such as PD-L1, indicating a role in shaping the immunosuppressive tumor microenvironment. Here, HSP90AA1 is linked to neoplasm.